PHK
RUBY

Point72 Hong Kong’s Rubius Therapeutics, Inc RUBY Stock Holding History

Point72 Hong Kong’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,735
Closed -$1K – 1861
2022
Q3 		$1K Buy
+1,735
New +$1.3K ﹤0.01% 1871
2022
Q1 		– Sell
-4,803
Closed -$46K – 2486
2021
Q4 		$46K Buy
4,803
+1,707
+55% +$23.7K ﹤0.01% 1367
2021
Q3 		$55K Buy
+3,096
New +$67.3K ﹤0.01% 1504
2021
Q2 		– Sell
-349
Closed -$9K – 2471
2021
Q1 		$9K Buy
+349
New +$5.1K ﹤0.01% 1600
2019
Q4 		– Sell
-35
Closed – – 1532
2019
Q3 		$0 Buy
+35
New +$408 ﹤0.01% 1447

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's RUBY Position: Q4 2022 in Review

Point72 Hong Kong sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 1,735 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in RUBY in Q3 2019 and held it in 5 quarters. The position peaked at $55K in Q3 2021. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Point72 Hong Kong reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,735 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Rubius Therapeutics, Inc in Q3 2019 and held it in 5 quarters.
  • Point72 Hong Kong's Rubius Therapeutics, Inc position peaked at $55K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.